News | PET-CT | September 13, 2017

Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017

Trial assessed the impact of F-18 PET/CT on patient management in biochemically recurrent prostate cancer patients scheduled for salvage treatment with curative intent

Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017

September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALCON clinical trial of fluciclovine (18F) positron emission tomography/computed tomography (PET/CT) at the 2017 American Society for Radiation Oncology (ASTRO) annual meeting Sept. 24-27 in San Diego. The FALCON trial evaluated the impact of F-18 PET/CT on patient management in biochemically recurrent prostate cancer patients scheduled for salvage radiation therapy treatment with curative intent. Trial results will be presented by Eugene Teoh, M.D., Oxford University Hospitals NHS Trust, Oxford, U.K.

Blue Earth Diagnostics is also hosting an Industry-Expert Theater event, “A Novel Option for Biochemically Recurrent Prostate Cancer Localization,” with invited speaker Abhishek Solanki, M.D., assistant professor of radiation oncology, Loyola University School of Medicine, Chicago, which will be held on Tuesday, Sept. 26.

For more information: www.blueearthdiagnostics.com

Related Content

GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...